Cargando…

Valproate-induced severe symptomatic hyponatremia in a patient with schizoaffective disorder: a case study and literature review

INTRODUCTION: The syndrome of inappropriate antidiuretic hormone secretion (SIADH) is a serious condition associated with persistently high ADH with water retention despite sufficient vascular volume. Sodium valproate (VPA), an antiepileptic indicated to treat bipolar disorder, blocks sodium (Na) an...

Descripción completa

Detalles Bibliográficos
Autores principales:	Heflin, K., ElSayed, M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cambridge University Press 2023
Materias:	Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10660874/ http://dx.doi.org/10.1192/j.eurpsy.2023.1174

Ejemplares similares

Valproate-induced hypothyroidism in schizoaffective disorder
por: Facucho-Oliveira, J., et al.
Publicado: (2022)

Schizoaffective disorder induced by substance abuse: a case report
por: García Carpintero, A., et al.
Publicado: (2022)

Schizoaffective disorder about 57 cases
por: Kammoun, I.
Publicado: (2021)

Treatment of severe symptomatic hyponatremia
por: Tandukar, Srijan, et al.
Publicado: (2019)

Novel use of granulocyte colony stimulating factor as an adjunct for treatment of schizoaffective disorder complicated by sodium valproate induced agranulocytosis
por: Subbarayan, S., et al.
Publicado: (2012)

Severe Symptomatic Hyponatremia Secondary to Escitalopram-Induced SIADH: A Case Report with Literature Review
por: Raj, Rishi, et al.
Publicado: (2018)

Management and outcome of symptomatic hyponatremia in emergency department
por: Kato, J, et al.
Publicado: (2000)

Hyponatremia severe and symptomatic in a critically ill infant
por: Mangia, CMF, et al.
Publicado: (2011)

Schizoaffective disorder: Nosological controversies and absence of specific treatment guidelines
por: García, M. Valtueña, et al.
Publicado: (2021)

Religious Coping Strategies for Religious Patients with Schizophrenia and Schizoaffective Disorder
por: Gedevani, E., et al.
Publicado: (2022)

The use of technologies and social media in patients with schizophrenia and schizoaffective disorder
por: Elleuch, O., et al.
Publicado: (2022)

Clinical factors affecting functioning in patients with schizophrenia or schizoaffective disorder
por: Neily, C., et al.
Publicado: (2022)

Clinical case of religious delusion in a combination of schizoaffective disorder and epilepsy
por: Gedevani, E., et al.
Publicado: (2022)

Impact of somatic and addictive comorbidities on the quality of life of patients with schizoaffective disorder
por: Bouali, W., et al.
Publicado: (2023)

Risk assessment of agressive behavior in schizophrenia and schizoaffective disorder : a cross-sectional study
por: Mellouli, A., et al.
Publicado: (2023)

Is schizoaffective disorder a distinct categorical diagnosis? A critical review of the literature
por: Abrams, Daniel J, et al.
Publicado: (2008)

To live with a Schizoaffective disorder
por: Arndtzén, Mats, et al.
Publicado: (2020)

PM395. The Effectiveness of Cross-Tapering Switching to Ziprasidone in Patients with Schizophrenia or Schizoaffective Disorder
por: Na, Kyoungsae, et al.
Publicado: (2016)

Socio-demographic, clinical and therapeutic features of patients treated for schizoaffective disorder using cannabis
por: Bouali, W., et al.
Publicado: (2023)

Acute Severe Symptomatic Hyponatremia Following Coronary Angiography
por: Jung, Eul Sik, et al.
Publicado: (2011)

Valproate-induced hyperammonemic encephalopathy. A case report
por: Cerame, A., et al.
Publicado: (2022)

Impact of Somatic and Addictive Comorbidities on the Quality of Life of Patients With Schizoaffective Disorder: A cross-sectional study
por: Asgharzadeh, M., et al.
Publicado: (2023)

SCHIZOAFFECTIVE DISORDER : CONSISTENCY OF DIAGNOSIS
por: Shrivastava, Amresh, et al.
Publicado: (1999)

Schizoaffective Disorder and Concurrent Rhabdomyolysis
por: Varkey, Thomas, et al.
Publicado: (2021)

Predictiting valproate toxicity in patients with mitochondrial disorders
por: Remenyi, Viktoria, et al.
Publicado: (2014)

Schizoaffective disorder in homeless patients: A systematic review
por: Spranger Forte, Alexandre, et al.
Publicado: (2022)

Pantoprazole-related Symptomatic Hyponatremia
por: Ferreira, Filipa, et al.
Publicado: (2016)

Clinical aspects of symptomatic hyponatremia
por: Weismann, Dirk, et al.
Publicado: (2016)

Should schizoaffective disorder be diagnosed cross-sectionally (ICD-11) instead of longitudinally (DSM-5)?: PRO
por: Falkai, P.
Publicado: (2021)

Should schizoaffective disorder be diagnosed cross-sectionally (ICD-11) instead of longitudinally (DSM-5)?: CON
por: Melle, I.
Publicado: (2021)

CT abnormalities in late-onset schizophrenia and schizoaffective disorder correlate with number of psychotic episodes and cognitive dysfunction
por: Savina, M., et al.
Publicado: (2021)

Valproate induced encephalopathy: Paradigm of normal ammonia levels
por: Barbosa, P., et al.
Publicado: (2021)

Severe symptomatic hyponatremia during citalopram therapy - a case report
por: Flores, Guillermo, et al.
Publicado: (2004)

Schizoaffective Disorder That Is Induced By Electrical Voltage That Is Treated with Risperidone
por: Fadhilah, Ihsan, et al.
Publicado: (2019)

Oxcarbazepine-induced hyponatremia: A case report
por: Pinto, M. Barbosa, et al.
Publicado: (2021)

Cyclophosphamide-induced symptomatic hyponatremia, a rare but severe side effect: a case report
por: Elazzazy, Shereen, et al.
Publicado: (2014)

Alcohol Use Disorder and Schizophrenia or Schizoaffective Disorder
por: Archibald, Luke, et al.
Publicado: (2019)

Reducing the Diagnostic Heterogeneity of Schizoaffective Disorder
por: Seldin, Katherine, et al.
Publicado: (2017)

Paliperidone Palmitate for Schizoaffective Disorder: A Review of the Clinical Evidence
por: Greenberg, William M., et al.
Publicado: (2015)

Cognitive Remediation Interventions in Schizoaffective Disorder: A Systematic Review
por: Lopez-Fernandez, Ester, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_53680ajv62lj5thnp0165p1tij